12.

Trial sequential analysis of 8 trials comparing PC6 acupoint and antiemetic versus antiemetic (despite risk of bias) for postoperative nausea, with control event proportion of 47.5%, diversity of 79%, α of 5%, power of 80%, and relative risk reduction of 30% (Apfel 2007).